2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde

Pellegrino Musto, Monika Engelhardt, Jo Caers, Niccolo' Bolli, Martin Kaiser, Niels W. C. J. van de Donk, Evangelos Terpos, Annemiek Broijl, Carlos Fernández de Larrea, Francesca Gay, Hartmut Goldschmidt, Roman Hajek, Annette Juul Vangsted, Elena Zamagni, Sonja Zweegman, Michele Cavo, Meletios A. Dimopoulos, Hermann Einsele, Heinz Ludwig, Giovanni BarosiMario Boccadoro, Maria Victoria Mateos, Pieter Sonneveld, Jesus San-Miguel

Research output: Contribution to journalReview articleAcademicpeer-review

28 Citations (Scopus)
23 Downloads (Pure)

Abstract

According to the updated International Myeloma Working Group criteria, smoldering multiple myeloma (SMM) is an asymptomatic plasma cell disorder characterized by an M-component >3 g/dL, bone marrow plasma cell infiltration >10% and
Original languageEnglish
Pages (from-to)2799-2812
JournalHaematologica
Volume106
Issue number11
Early online date15 Jul 2021
DOIs
Publication statusPublished - Nov 2021

Fingerprint

Dive into the research topics of '2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde'. Together they form a unique fingerprint.

Cite this